Innovative strategies to increase engraftment of engineered hematopoietic stem cells and bypass genotoxic conditioning, toward the next-generation gene therapy

Project Information

IMPROVING-GT

Grant agreement ID: 101031856

DOI

10.3030/101031856

Project closed

EC signature date 22 April 2021

Start date 1 January 2022

End date 31 December 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 183 473,28

EU contribution

€ 183 473,28

Coordinated by

OSPEDALE SAN RAFFAELE SRL
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

Author(s): Omer-Javed, A., Pedrazzani, G., Albano, L., Ghaus, S., Latroche, C., Manzi, M., Ferrari, S., Fiumara, M., Jacob, A., Vavassori, V., Nonis, A., Canarutto, D., & Naldini, L.
Published in: Cell, Issue 185(13), 2248–2264.e21, 2022, ISSN 0092-8674
Publisher: Cell Press
DOI: 10.1016/j.cell.2022.04.039

Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation

Author(s): Canarutto, D., Omer Javed, A., Pedrazzani, G., Ferrari, S., & Naldini, L.
Published in: British medical bulletin, Issue 147(1), 108–120, 2023, ISSN 0007-1420
Publisher: Oxford University Press
DOI: 10.1093/bmb/ldad017